Hantavirus is not a single virus. This post explains why Taiwan’s Seoul virus cases and the MV Hondius Andes virus outbreak should not be conflated, highlighting their different reservoirs, disease risks, transmission patterns, and public health implications.

Before your body produces specific antibodies against a new invader, a powerful defense system is already hard at work. Meet the complement system— one of the immune system’s fastest and most sophisticated weapons. This ancient cascade of proteins can detect, tag, and destroy pathogens within minutes, while also bridging innate and adaptive immunity.

DNA damage research is central to understanding cancer, aging, neurodegeneration, reproductive health, and drug development. This post explains how cells detect and repair damaged DNA through the DNA damage response, highlights key biomarkers like γH2AX, 53BP1, RAD51, and p53, and explores why reliable research tools are essential for studying genome integrity.

Bioss is excited to announce the 2026 Bioss Travel Grant, created to help support researchers attending scientific conferences and sharing their work with the broader research community.

From major meetings like AACR, AAI, and SfN to other antibody-related scientific conferences, Bioss is proud to support researchers as they present discoveries, build collaborations, and engage with their scientific peers.

From cancer studies to neurodevelopment, from infectious disease models to regenerative medicine, organoids are emerging as a vital bridge between fundamental research and clinical applications.

A scientific perspective vividly describes proteins as locks and small-molecule activators or inhibitors as perfectly matched keys— they insert, turn, or jam the lock, thereby controlling the entire machinery of life. This metaphor, rooted in the classic "lock-and-key model" proposed by Emil Fischer in 1894, continues to gain new vitality in modern drug discovery and biology.